SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-015095
Filing Date
2023-11-14
Accepted
2023-11-14 16:38:55
Documents
1
Period of Report
2023-11-10

Document Format Files

Seq Description Document Type Size
1 form4-11142023_091146.html 4  
1 form4-11142023_091146.xml 4 3450
  Complete submission text file 0001415889-23-015095.txt   4912
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLILN OH 43017
Business Address
Dais Craig (Reporting) CIK: 0001990095 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35076 | Film No.: 231407251